5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
This study is currently recruiting participants.
Verified June 2013 by Krankenhaus Nordwest
Sponsor:
Krankenhaus Nordwest
Information provided by (Responsible Party):
Krankenhaus Nordwest
ClinicalTrials.gov Identifier:
NCT01216644
First received: June 30, 2010
Last updated: June 3, 2013
Last verified: June 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | July 2015 (Final data collection date for primary outcome measure) |